3Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prolgosis. Nordic Myeloma Study Group. Eur J Haematol,2000,65(3) : 175 - 181.
4Montseny J J, Kleinknecht D, Meyrier A, et al. Long - term outcome according to renal histological lesions in 118 patients with monoelonal gammopathies. Nephrol Dial Transplant, 1998, 13(6) : 1438 - 1445.
5Dzsquall S, Casanova S, Zucchelli A, et al. Long- term survival patients with acute and severe renal failure due to multiple myeloma. Clin Nephrol, 1990,34 (6) : 247 - 254.
6Abbott KC, Agodoa LY. Multiple myelorna and light chainassociated nephropathy at end stage renal disease in the United States: patient characteristics and survival. Clin Nephrol, 2001,56 (3) : 207 - 217.
7Viertel A, Weidrnann E, Ditting T, et al. Management of renal complications in patients with advanced multiple myeloma. Leuk Lymphorna, 2000,38( 5 - 6) : 513 - 519.
8Sakhuja J ,Jha V,Varma S,et al. Renal involvement in multiple myeloma: a 10 - year study. Ren Fail, 2000,22 (4) : 465 - 477.
9Kim YT,Rha SY,Shim CY,et al.A case of paraneoplastic nephritic syndrome in a patient with ovarian carcinoma.Yonsei Med J,2003,44(3):539
3Cockcroft DW, Gauh MH. Prediction of creatinine clearance from serum creatinine[ J]. Nephron, 1976,16:31-41.
4O'Reilly S, Bowinsky EK, Slichenmyer W, et al. Phase I and pharmacologic study of topotecan in patients with impaired renal function [ J ]. J Clin Oncol, 1996,14 : 3062- 3073.
5Takimoto CH, Remick SC, Sharma S, et al. Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired renal function:a National Cancer Institute Organ Dysfunction Working Group Study [ J ]. J Clin Oncol, 2003,21 : 2664 -2672.
6Li YF, Gershenson DM, Kavanagh JJ. Systemic anticancer therapy in gynecological cancer patients with renal function [ J ]. Int J Gynecol cancer,2008,4 : 13-18.
7Bodnara L, Wcisloa G. Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: A randomised phase II study [ J ]. Eur J Cancer,2008,44:2608-2614.
8Watanabe R, Takiguchi Y, Moriya T, et al. Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer [ J ]. Br J Cancer, 2003,88 : 25-30.
9Ribrag V, Droz JP, Morizet J, et al. Test dose-guided administration of cisplatin in an anephric patient : a case report [ J ]. Ann Oncol, 1993,4:679-682.
10Gouyette A, Lemoine R, Adhemar JP, et al. Kinetics of cisplatin in an anuric patient undergoing hemofihration dialysis [ J ]. Cancer Treat Rep, 1981,65 : 665-668.
